IRCT20170912036157N2招募中3 期
Assessment of response to treatment in anemia (iron deficiency) after CABG in adults
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 142
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 72 years（—）
- 性别
- All
入选标准
- •Age between 18 until 72 years
- •Patients are candidates for CABG for the first time
- •Hemoglobin is less than 10 in women and less than 11 in men
排除标准
- •History of previous surgery
- •Kidney disorders
- •Autoimmune diseases
- •Bleeding disorders,
- •Thalassemia
研究者
相似试验
暂停
不适用
Examination of the effect of improving anemia / taste disorder by administration of zinc supplementation to chronic kidney disease exhibiting hypozincemiaJPRN-UMIN000031655Juntendo University500
已完成
不适用
The effect of treating patients with anaemia in diabetic nephropathy to different target haemoglobin levels with epoetin betaAnaemia in diabetic nephropathyHaematological DisordersAnaemiaISRCTN66395033Barts and the London NHS Trust (UK)160
招募中
不适用
POST-operative Variations in anaemia treatmenT and Transfusions (POSTVenTT)ACTRN12621001517864South Metropolitan Health Service (SMHS)2,000
进行中（未招募）
1 期
The Effect of Treating Patients with Anaemia in Diabetic Nephropathy to different target haemoglobin levels with Epoetin Beta - Epoetin Beta in ADAnaemia in Diabetic NephropathyMedDRA version: 8.1Level: LLTClassification code 10002071Term: Anaemia NOSEUCTR2006-004775-35-GBBarts and the London NHS Trust
招募中
1 期
Phase 2 Study of Luspatercept in Adults and Adolescents with Alpha (a)-thalassemiaAlpha (a)-thalassemiaMedDRA version: 20.1Level: LLTClassification code: 10054659Term: Thalassemia alpha Class: 10010331CTIS2022-502328-35-00Celgene Corp.177